Literature DB >> 4452943

Linear and nonlinear kinetics of drug elimination. I. Kinetics on the basis of a single capacity-limited pathway of elimination with or without simultaneous supply-limited elimination.

C A van Ginneken, J M van Rossum, H L Fleuren.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4452943     DOI： 10.1007/BF01071310

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  7 in total

1.  The kinetics of alcohol elimination in man.

Authors:  F LUNDQUIST; H WOLTHERS
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1958

2.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.

Authors:  G Levy; T Tsuchiya; L P Amsel
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

Review 3.  Liver adaptation and injury in alcoholism.

Authors:  C S Lieber
Journal:  N Engl J Med       Date:  1973-02-15       Impact factor: 91.245

4.  Variations in absorption and elimination rates of ethyl alcohol in a single subject.

Authors:  J G Wagner; J A Patel
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-07

5.  Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  Kinetics of diphenylhydantoin elimination in rats.

Authors:  J J Ashley; G Levy
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

7.  Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.

Authors:  A J Glazko; T Chang; J Baukema; W A Dill; J R Goulet; R A Buchanan
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875
  7 in total
  9 in total

1.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

Review 2.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  Non-linear kinetics of 4-methylpyrazole in healthy human subjects.

Authors:  D Jacobsen; S K Barron; C S Sebastian; R Blomstrand; K E McMartin
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Simultaneous kinetic modelling of plasma levels and urinary excretion of salicyluric acid, and the influence of probenecid.

Authors:  P Hekman; C A van Ginneken
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

5.  Measurement of excretion characteristics of theophylline and its major metabolites.

Authors:  J H Jonkman; D Tang; R A Upton; S Riegelman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Barriers to Building More Effective Treatments: Negative Interactions Amongst Smoking Intervention Components.

Authors:  Timothy B Baker; Daniel M Bolt; Stevens S Smith
Journal:  Clin Psychol Sci       Date:  2021-04-26

7.  Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers.

Authors:  P Palatini; L Tedeschi; G Frison; R Padrini; R Zordan; R Orlando; L Gallimberti; G L Gessa; S D Ferrara
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Disposition of azole antifungal agents. II. Hepatic binding and clearance of dichlorophenyl-bis-triazolylpropanol (DTP) in the rat.

Authors:  H L Bomont; M H Tarbit; M J Humphrey; J B Houston
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  Evaluation of Lidocaine and Metabolite Pharmacokinetics in Hyaluronic Acid Injection.

Authors:  Ju Hee Kim; Dong Wook Kang; Go-Wun Choi; Sang Bok Lee; Seongjin Lee; Hea-Young Cho
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.